Search the global news on our network companies
A comprehensive source of news from our network. With the latest from companies appearing on our platform, around the globe, we deliver an extensive summary of news, press releases and information directly from the companies and other authoritative industry news sources.
Search and filter the results by company or location to find the news that matters to you.
If you would like to publish news on behalf of your company, please register with us at the following link https://www.pharmaservicesdirectory.com/register
Save
This Search |
View as Grid
| Order by Recently Added
| Order
by Company Name
- Total Results: 945
- Total Pages: 119
Repertoire® Immune Medicines and Bristol Myers Squibb Announce Multi-Year Strategic Collaboration
Collaboration combines Repertoire’s industry leading DECODE™ platform that uniquely maps the immune synapse to develop T cell targeted immune medicines with Bristol Myers Squibb’s world-leading expertise in developing and commercializing innovative immune medicines
Repertoire will receive an upfront payment of $65 million and is eligible to receive up to $1.8 billion in milestone and other payments and tiered royalties
View original story »
Manage Your Profile
PeptiDream Announces Expansion of Peptide Discovery Collaboration with Novartis
KANAGAWA, JAPAN –Apr. 30 th , 2024 – PeptiDream Inc., a public Kanagawa, Japanbased biopharmaceutical company (President and CEO: Patrick C. Reid, hereinafter “PeptiDream”) (Tokyo: 4587) today announced an expansion of its peptide discovery collaboration with Swiss-based Novartis Pharma AG (“hereinafter Novartis”) (NYSE: NVS). Under the multi-program agreement, PeptiDream will use its proprietary Peptide Discovery Platform System (“PDPS®”) technology to identify and optimize novel macrocyclic peptides against targets selected by Novartis, for potential conjugation to radionuclides (to which…
Read more on this story »
Manage Your Profile
Poolbeg Pharma enters Exclusive Option Agreement for novel Behçet’s Disease treatment
Poolbeg Pharma plc (LON:POLB, OTCQB: POLBF), a biopharmaceutical company focussed on the development and commercialisation of innovative medicines targeting diseases with a high unmet medical need, announces that it has entered into an exclusive 12-month option agreement with Silk Road Therapeutics Inc, for a nominal fee, to acquire a novel topical muco-adherent formulation of Pentoxifylline (tPTX) for…
Read more on this story »
Manage Your Profile
Vertex and TreeFrog Therapeutics Enter Licensing Agreement and Partnership on Production of Type 1 Diabetes Cell Therapies
Vertex Pharmaceuticals, a global biotechnology company, and TreeFrog Therapeutics, a biotechnology company based in France, announced that Vertex has acquired an exclusive license to C-Stem, TreeFrog’s proprietary cell manufacturing technology, in order to optimize production of Vertex’s cell therapies for type 1 diabetes (T1D). The collaboration aims to scale-up TreeFrog’s process to produce and amplify cells for Vertex’s T1D therapies. C-Stem is designed to imitate the natural microenvironment, which allow cells to continuously grow in 3D. Through C-Stem, Vertex can create…
Read more on this story »
Manage Your Profile
Vertex and TreeFrog Therapeutics Announce Licensing Agreement and Collaboration
BOSTON and BORDEAUX, France – April 23, 2024 – Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and TreeFrog Therapeutics today announced that Vertex has obtained an exclusive license to TreeFrog’s proprietary cell manufacturing technology, C-StemTM, to optimize production of Vertex’s cell therapies for type 1 diabetes (T1D). TreeFrog and Vertex will collaborate to scale-up TreeFrog’s process to produce and amplify cells for Vertex’s T1D therapies. TreeFrog’s proprietary technology platform, C-Stem™, is designed…
Read more on this story »
Manage Your Profile
Predictive Oncology Announces Collaboration with Integra Therapeutics to Advance Gene Therapy
Integra Therapeutics selected Predictive Oncology because of the company’s protein expression experience and unique ability to optimize solubility and physical stability for expressed proteins. Predictive Oncology uses a proprietary automated technology, called high-throughput self-interaction chromatography (HSC™), to rapidly and accurately measure biomolecular interactions that assist pharmaceutical and biotech companies in drug development.
View original story »
Manage Your Profile
Regeneron and Mammoth Biosciences Collaborate to Pursue Next-Generation CRISPR-Based Gene Editing for Multiple Diseases
TARRYTOWN, N.Y. and BRISBANE, Calif., April 25, 2024 – Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) and Mammoth Biosciences, Inc., today announced a collaboration to research, develop and commercialize in vivo CRISPR-based gene editing therapies for multiple tissues and cell types. Regeneron is developing adeno-associated viral vectors (AAVs) using antibody-based targeting to enhance delivery of genetic medicine payloads to specific…
Read more on this story »
Manage Your Profile
Boehringer Ingelheim Biopharmaceuticals China receives approval for supply of EU and US markets
Boehringer Ingelheim Biopharmaceuticals China (BioChina), in collaboration with a customer, has successfully passed pre-approval inspections by the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA).
View original story »
Manage Your Profile
- Total Results: 945
- Total Pages: 119
Network News
Keeping the latest and up-to-date news on our companies is a key activity of the editorial team.
We support companies directly through the profiles to allow them update their profile with the latest news and company announcements. Search fields are provided so that you can access news by company name, sector e.g research, manufacturing, equipment, packaging or geography.
The global news is updated daily and its aim is to provide you as a directory user with the information needed to make good buying or supply choices. News covers companies operating within the pharmaceutical, biotechnology, medical device and nutraceutical sectors.
Also through our software applications you can evaluate, rate and score news and company announcements to support corporate risk management activities. Through the software applications it is possible to supplement and add your own news items, keeping a library of news activities on any company identified through the directory.
Take the Next Step
Should you have any questions or require further information please contact us ...
Contact the support team »
Check if your company is listed and claim your online profile ...
Search for your company listing »
If you're not listed in the directory and you want to build a public profile, register for an account ...
Register for an account to build a profile »
Apply for a free trial of our Supplier Management Software ...
Register for an account to trial the software »
